# Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

> **NCT01628029** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 68 (actual)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Sleep Disorder

## Interventions

- **OTHER:** Counseling
- **DRUG:** Methylphenidate Hydrochloride
- **PROCEDURE:** Phototherapy
- **OTHER:** Placebo Administration
- **OTHER:** Quality-of-Life Assessment
- **PROCEDURE:** Sham Intervention
- **DRUG:** Therapeutic Melatonin

## Key facts

- **NCT ID:** NCT01628029
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-01-15
- **Primary completion:** 2025-12-22
- **Final completion:** 2028-12-31
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01628029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01628029, "Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01628029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*